NCT00140972View on ClinicalTrials.gov

A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED)

PHASE4CompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

December 3, 2004

Primary Completion Date

June 27, 2005

Study Completion Date

June 27, 2005

Conditions

Osteoarthritis

Interventions

DRUG

MK0663; etoricoxib / Duration of Treatment:4 Weeks

DRUG

Comparator: diclofenac sodium tablet 75 mg / Duration of Treatment:4 Weeks

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00140972 - A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED) | Biotech Hunter | Biotech Hunter